Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anjali Sangeeth

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Drug Targets|September 19, 2022
Long Non-coding RNA Therapeutics: Recent Advances and ChallengesAnjali Sangeeth, Mahesh Malleswarapu, Amit Mishra, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 6, 2022
Long Non-Coding RNAs as Cellular Metabolism and Haematopoiesis RegulatorsAnjali Sangeeth, Mahesh Malleswarapu, Amit Mishra, et al.
Cancer Immunology, Immunotherapy : CII|April 23, 2021
Megakaryoblastic leukemia: a study on novel role of clinically significant long non-coding RNA signatures in megakaryocyte development during treatment with phorbol esterSwati Dahariya, Sanjeev Raghuwanshi, Anjali Sangeeth, et al.
Oncology Research|June 9, 2025
Mitochondrial micro RNAs: Crucial players in carcinogenesisAshutosh Kumar Maurya, Anjali Sangeeth, Rabina Punathil, et al.
Development (Cambridge, England)|June 24, 2025
miR-137 targets Myc to regulate growth during eye developmentRadhika Padma, Manivannan Subramanian, Anuradha Venkatakrishnan Chimata, et al.
Cellular Signalling|January 14, 2021
Co-stimulatory effect of TLR2 and TLR4 stimulation on megakaryocytic development is mediated through PI3K/NF-ĸB and XBP-1 loopNarasaiah Kovuru, Sanjeev Raghuwanshi, Anjali Sangeeth, et al.
Journal of Neuroimmunology|February 11, 2021
Endocannabinoid system: Role in blood cell development, neuroimmune interactions and associated disordersDurga Shankar Sharma, Indira Paddibhatla, Sanjeev Raghuwanshi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Drug Targets|September 19, 2022
Long Non-coding RNA Therapeutics: Recent Advances and ChallengesAnjali Sangeeth, Mahesh Malleswarapu, Amit Mishra, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 6, 2022
Long Non-Coding RNAs as Cellular Metabolism and Haematopoiesis RegulatorsAnjali Sangeeth, Mahesh Malleswarapu, Amit Mishra, et al.
Cancer Immunology, Immunotherapy : CII|April 23, 2021
Megakaryoblastic leukemia: a study on novel role of clinically significant long non-coding RNA signatures in megakaryocyte development during treatment with phorbol esterSwati Dahariya, Sanjeev Raghuwanshi, Anjali Sangeeth, et al.
Oncology Research|June 9, 2025
Mitochondrial micro RNAs: Crucial players in carcinogenesisAshutosh Kumar Maurya, Anjali Sangeeth, Rabina Punathil, et al.
Development (Cambridge, England)|June 24, 2025
miR-137 targets Myc to regulate growth during eye developmentRadhika Padma, Manivannan Subramanian, Anuradha Venkatakrishnan Chimata, et al.
Cellular Signalling|January 14, 2021
Co-stimulatory effect of TLR2 and TLR4 stimulation on megakaryocytic development is mediated through PI3K/NF-ĸB and XBP-1 loopNarasaiah Kovuru, Sanjeev Raghuwanshi, Anjali Sangeeth, et al.
Journal of Neuroimmunology|February 11, 2021
Endocannabinoid system: Role in blood cell development, neuroimmune interactions and associated disordersDurga Shankar Sharma, Indira Paddibhatla, Sanjeev Raghuwanshi, et al.
Pageof 1